Adrenocortical carcinoma is a rare heterogeneous neoplasm with an incompletely understood pathogenesis and a poor prognosis. No general consensus on the diagnostic and therapeutic measures for adrenocortical carcinoma exists, but collaborative efforts have substantially advanced the field. This Review provides an updated approach to the patient with suspected adrenocortical carcinoma and discusses etiology, diagnosis and treatment options.
- Martin Fassnacht
- Rossella Libé
- Bruno Allolio